Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Megakaryocytes | 2 | 2023 | 542 | 1.200 |
Why?
|
| Blood Platelets | 5 | 2023 | 2506 | 0.840 |
Why?
|
| Honey | 1 | 2020 | 11 | 0.760 |
Why?
|
| Macaca mulatta | 4 | 2018 | 2378 | 0.630 |
Why?
|
| Dengue Vaccines | 1 | 2017 | 14 | 0.600 |
Why?
|
| Sepsis | 2 | 2023 | 2589 | 0.600 |
Why?
|
| Monkey Diseases | 1 | 2017 | 77 | 0.590 |
Why?
|
| Thrombophilia | 1 | 2020 | 305 | 0.590 |
Why?
|
| Cytoplasm | 1 | 2020 | 1539 | 0.520 |
Why?
|
| Titanium | 2 | 2017 | 494 | 0.510 |
Why?
|
| Blood Coagulation | 3 | 2022 | 1126 | 0.500 |
Why?
|
| Ligaments | 1 | 2014 | 127 | 0.470 |
Why?
|
| Dog Diseases | 1 | 2014 | 136 | 0.460 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 687 | 0.460 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3862 | 0.410 |
Why?
|
| Helicobacter pylori | 1 | 2015 | 381 | 0.400 |
Why?
|
| Helicobacter Infections | 1 | 2015 | 385 | 0.400 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 3 | 2020 | 425 | 0.390 |
Why?
|
| Staphylococcal Infections | 1 | 2020 | 1398 | 0.390 |
Why?
|
| Microfluidics | 1 | 2016 | 662 | 0.380 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2015 | 232 | 0.380 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 1538 | 0.380 |
Why?
|
| Tendon Injuries | 1 | 2014 | 313 | 0.380 |
Why?
|
| Femoral Fractures | 1 | 2014 | 376 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 7153 | 0.350 |
Why?
|
| Histones | 1 | 2020 | 2597 | 0.350 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 1385 | 0.340 |
Why?
|
| Cell Communication | 1 | 2016 | 1619 | 0.340 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 1171 | 0.340 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 1668 | 0.300 |
Why?
|
| Neutrophils | 2 | 2017 | 3711 | 0.300 |
Why?
|
| Cell Movement | 1 | 2016 | 5212 | 0.240 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 2130 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.200 |
Why?
|
| Pandemics | 1 | 2020 | 8328 | 0.170 |
Why?
|
| Venous Pressure | 1 | 2017 | 56 | 0.160 |
Why?
|
| Microvessels | 1 | 2022 | 544 | 0.150 |
Why?
|
| Factor VIII | 1 | 2020 | 348 | 0.150 |
Why?
|
| Needles | 1 | 2020 | 448 | 0.150 |
Why?
|
| Hyphae | 1 | 2017 | 56 | 0.150 |
Why?
|
| Antithrombin III | 1 | 2017 | 128 | 0.140 |
Why?
|
| Alloys | 1 | 2017 | 122 | 0.140 |
Why?
|
| Jugular Veins | 1 | 2017 | 204 | 0.140 |
Why?
|
| Chemotactic Factors | 1 | 2016 | 199 | 0.140 |
Why?
|
| Aspergillus fumigatus | 1 | 2017 | 150 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 2505 | 0.130 |
Why?
|
| Osteolysis | 1 | 2017 | 270 | 0.130 |
Why?
|
| Phylogeography | 1 | 2015 | 81 | 0.130 |
Why?
|
| Aspergillosis | 1 | 2017 | 235 | 0.130 |
Why?
|
| Blood Proteins | 1 | 2020 | 1122 | 0.120 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2015 | 293 | 0.120 |
Why?
|
| Molecular Mimicry | 1 | 2015 | 201 | 0.120 |
Why?
|
| P-Selectin | 1 | 2016 | 600 | 0.120 |
Why?
|
| Platelet Aggregation | 1 | 2017 | 800 | 0.120 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2014 | 195 | 0.120 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 2645 | 0.110 |
Why?
|
| Spermatogenesis | 1 | 2014 | 262 | 0.110 |
Why?
|
| Dogs | 2 | 2017 | 3910 | 0.110 |
Why?
|
| Hemostasis | 1 | 2016 | 458 | 0.110 |
Why?
|
| Metals | 1 | 2017 | 717 | 0.110 |
Why?
|
| Leiomyoma | 1 | 2018 | 728 | 0.110 |
Why?
|
| Immunization, Passive | 1 | 2015 | 625 | 0.110 |
Why?
|
| Skull | 1 | 2017 | 810 | 0.110 |
Why?
|
| Urinary Bladder | 1 | 2018 | 1171 | 0.100 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 1017 | 0.100 |
Why?
|
| Platelet Activation | 1 | 2015 | 671 | 0.100 |
Why?
|
| Hip Prosthesis | 1 | 2017 | 917 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2023 | 2956 | 0.100 |
Why?
|
| Cell Line | 2 | 2023 | 15994 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 2699 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 1538 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2020 | 4143 | 0.090 |
Why?
|
| Wound Healing | 1 | 2020 | 2781 | 0.080 |
Why?
|
| Antigens, Bacterial | 1 | 2015 | 1170 | 0.080 |
Why?
|
| Models, Animal | 1 | 2016 | 2170 | 0.080 |
Why?
|
| Iron | 1 | 2017 | 1773 | 0.080 |
Why?
|
| Reference Values | 1 | 2016 | 4982 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 1731 | 0.080 |
Why?
|
| Anticoagulants | 2 | 2022 | 4595 | 0.080 |
Why?
|
| Antibodies | 1 | 2016 | 2459 | 0.080 |
Why?
|
| Thrombosis | 1 | 2022 | 2966 | 0.080 |
Why?
|
| Computational Biology | 2 | 2022 | 3518 | 0.080 |
Why?
|
| Patient Selection | 1 | 2020 | 4214 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 2099 | 0.070 |
Why?
|
| Models, Biological | 2 | 2022 | 9581 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2015 | 1348 | 0.070 |
Why?
|
| Animals | 7 | 2018 | 168561 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2017 | 5975 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2017 | 1461 | 0.070 |
Why?
|
| Antibodies, Viral | 1 | 2017 | 3164 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7770 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2195 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 2229 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3769 | 0.070 |
Why?
|
| Comorbidity | 1 | 2020 | 10372 | 0.060 |
Why?
|
| Time Factors | 2 | 2017 | 40054 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19223 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2017 | 5978 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3151 | 0.060 |
Why?
|
| Male | 8 | 2020 | 349538 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 7901 | 0.060 |
Why?
|
| Humans | 10 | 2023 | 742088 | 0.060 |
Why?
|
| Prevalence | 1 | 2020 | 15194 | 0.050 |
Why?
|
| Blood Viscosity | 1 | 2022 | 124 | 0.050 |
Why?
|
| Hemorheology | 1 | 2022 | 145 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4147 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2017 | 9144 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 3843 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 15494 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2022 | 894 | 0.040 |
Why?
|
| Phenotype | 1 | 2016 | 16331 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17400 | 0.040 |
Why?
|
| Chromium Alloys | 1 | 2017 | 77 | 0.040 |
Why?
|
| Female | 5 | 2020 | 379592 | 0.040 |
Why?
|
| Polyethylene | 1 | 2017 | 184 | 0.030 |
Why?
|
| Spermatids | 1 | 2014 | 36 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15244 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 72145 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2014 | 230 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 1203 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 847 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2014 | 407 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2014 | 880 | 0.020 |
Why?
|
| Equipment Design | 1 | 2017 | 3582 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 1144 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 62966 | 0.020 |
Why?
|
| Reoperation | 1 | 2017 | 4200 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 4211 | 0.020 |
Why?
|
| Adult | 2 | 2017 | 213712 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 12958 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4664 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 213127 | 0.010 |
Why?
|
| Algorithms | 1 | 2017 | 13853 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 56350 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 81045 | 0.000 |
Why?
|
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_